Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Pharmaceutical Drug Product Development
Addressing the increasing pressure on pharmaceutical companies to bring clinical candidates through their pipeline faster and with greater efficiency, we provide expert pharmaceutical drug product development solutions.
Operating from state-of-the-art, custom designed facilities, our scientists can develop your clinical candidates into optimum formulations and manufacture solid oral dose products for all stages of clinical trials.
From developing a fit-for-purpose formulation for First-in-Human trials, to scaling up for late phase trials and ultimately commercialisation, our pharmaceutical drug product development solutions are customised to meet your needs.
Meeting increased client demand, we have expanded our pharmaceutical drug product development services through the acquisition of two linked facilities located within the Charnwood Campus in Loughborough, UK. These purpose-built facilities provide a significant increase in our solid oral dose drug product development, manufacturing and analytical testing capacity ensuring we can meet your future pharmaceutical development and manufacturing needs.